PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 6 filers reported holding PDL BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $314,000 | +163.9% | 147,992 | +288.9% | 0.03% | +142.9% |
| Q2 2016 | $119,000 | -79.4% | 38,056 | -78.1% | 0.01% | -93.5% |
| Q1 2016 | $579,000 | +24.5% | 173,813 | +32.3% | 0.22% | -2.7% |
| Q4 2015 | $465,000 | +114.3% | 131,402 | +204.2% | 0.22% | +276.3% |
| Q3 2015 | $217,000 | -25.9% | 43,200 | +13.5% | 0.06% | -61.7% |
| Q4 2014 | $293,000 | -85.0% | 38,055 | -85.5% | 0.15% | -69.1% |
| Q3 2014 | $1,954,000 | +327.6% | 261,620 | +453.9% | 0.50% | +286.8% |
| Q2 2014 | $457,000 | +54.9% | 47,229 | +32.9% | 0.13% | +34.4% |
| Q1 2014 | $295,000 | -48.1% | 35,525 | -47.2% | 0.10% | -10.3% |
| Q4 2013 | $568,000 | +314.6% | 67,330 | +279.6% | 0.11% | +197.2% |
| Q2 2013 | $137,000 | – | 17,739 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |